Can You Trademark Your Way Out of Bad PR? Delhi HC Fines Niva Bupa Re. 1 for Trying

/ By / Trademark

Recently, the Delhi High Court, in Niva Bupa v. Vishal Rattewal imposed Re. 1 in notional costs after finding the plaintiffs’ suit to be a “misuse” of the IPD’s special jurisdiction. In this post, Aryan Agrawal examines whether the failure of a trademark infringement claim is sufficient to constitute such misuse, and whether the Court adequately considered the IPD Rules’ express inclusion of disparagement within its remit. Aryan is an advocate practising before the Delhi High Court and an Associate

Can You Trademark Your Way Out of Bad PR? Delhi HC Fines Niva Bupa Re. 1 for Trying Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (October 19-October 25)

/ By / Copyright, Design, Patent, Trademark

A quick tidbit on the free online version of Feroz Ali’s treatise on patent law, interesting orders from various High Courts, and exciting national and international IP developments in this week’s SpicyIP Weekly Review. Anything we’ve missed? Drop a comment and let us know! Highlights of the Week SpicyIP Tidbit: Ali on Patents – A Treatise Built for Reading, Citing and Keeping Up Patent research often means working through lengthy judgments to find the reasoning that matters. Prof. Feroz Ali’s

SpicyIP Weekly Review (October 19-October 25) Read More »

SpicyIP Bells & Whistles: IP Events and Opportunities (26.10.2026)

/ By / Courses & Workshops, Opportunities

Welcome back to another week of Bells & Whistles. As always, we’ve rounded up a mix of developments, opportunities, and thoughtful reads from across the IP world along with a Bell of the Week that’s well worth revisiting. Bell of the Week: Copyright at 50 – Can the Law Keep Up? Copyright law has always had to contend with a rather difficult question: how do you make rules for creative works when the ways we create, share and use them

SpicyIP Bells & Whistles: IP Events and Opportunities (26.10.2026) Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (October 12-October 18)

/ By / Copyright, Drug Regulation, Patent, Trademark

[This Weekly Review is prepared by Kaustub Boidi. Kaustub is a final-year law student at SVKM’s NMIMS, Hyderabad.] Here’s this week’s roundup of IP developments, from posts on the Kerala High Court’s Ribociclib decision, the Delhi HC’s tiered approach to patent appeals in Esteve Pharmaceuticals, the PABS Annex of the WHO Pandemic Agreement, to key judicial decisions and national and international IP updates. Anything we missed out on? Drop a comment below to let us know! Highlights of the Week

SpicyIP Weekly Review (October 12-October 18) Read More »

SpicyIP Tidbit: Ali on Patents – A Treatise Built for Reading, Citing and Keeping Up

/ By / Patent

Prof. Feroz Ali has launched Ali on Patents (www.aop.onl), a free, online version of the treatise he first published in 2007. In his launch note on linkedin, he says that everything on the site is either his own words or the words of the court, with no AI-written prose in between. The resource is meant for a wide readership: patent lawyers and agents, in-house counsel, examiners, judges, academics, students and inventors, among others. The site has two kinds of pages:

SpicyIP Tidbit: Ali on Patents – A Treatise Built for Reading, Citing and Keeping Up Read More »

Equitable Pandemic Response: Delink Data Access from Benefit Sharing in the PABS Annex

/ By / Patent

Long Post Ahead! In May 2025, the World Health Organization’s member states adopted the Pandemic Agreement. However, until its Pathogen Access and Benefit-Sharing (PABS) Annex is adopted, it cannot be opened for signature. Currently, the talks on the annex remain stuck on one question: should benefit sharing be tied to access to pathogen data? In this post, I argue that this linkage is itself the problem. Drawing on the model proposed by Knowledge Ecology International (KEI) before the Intergovernmental Working

Equitable Pandemic Response: Delink Data Access from Benefit Sharing in the PABS Annex Read More »

Call for Submisisons: Journal of Intellectual Property Laws(JIPL), Volume X (Deadline: 30 November 2026)

/ By / Opportunities, Publication

The Centre for Intellectual Property Rights (CIPR), Institute of Law, Nirma University is inviting submissions for the Journal of Intellectual Property Laws(JIPL), Volume X. The last date for submission is 30 November. For more details, read the call for submissions below:- Call for Submissions: Journal of Intellectual Property Laws(JIPL), Volume X (Deadline: 30 November 2026) About the Organizer Founded in 2007 under the vision of Dr Karsanbhai K. Patel, the Institute of Law, Nirma University seeks to bring newer dimensions

Call for Submisisons: Journal of Intellectual Property Laws(JIPL), Volume X (Deadline: 30 November 2026) Read More »

The Ghost of Section 100’s Past!

/ By / Drug Regulation, Others, Overlaps in IP, Patent

As Halloween approaches, a particular editorial at ET seems spooked by the prospect of lawful and equitable access to medicines! In doing the opposite of what its title suggests, ‘Protect Patients and Patents Smartly’, the editorial piece published on October 15, 2026 is an unfortunate example of legal misinformation and misinterpretation, stuck in the old binary of access versus patent. This published piece runs contrary to years of judicial wisdom, contradicts itself, conflates different legal questions and advocates for a

The Ghost of Section 100’s Past! Read More »

SpicyIP Tidbit: Putting the Cart Before the Horse: A Look into Esteve Pharmaceuticals vs CPD

/ By / Patent

In the August 7 order passed in Esteve Pharmaceuticals S.A. vs Controller of Patents and Designs (2026), the Delhi High Court adopted a tiered approach in examining the grounds for rejecting a patent application. It accepted that the invention “Co-crystals of Tramadol and Coxibs” was novel (differing from the Controller on 2(1)(j)), but it lacked inventive step (upholding the Controller’s objections under 2(1)(ja)). And because it lacked inventive step, the Court did not find examining further under 3(d) and 3(e)

SpicyIP Tidbit: Putting the Cart Before the Horse: A Look into Esteve Pharmaceuticals vs CPD Read More »

SpicyIP Bells & Whistles: IP Events and Opportunities (13.10.2026)

/ By / Courses & Workshops, Opportunities

Welcome back to another week of Bells & Whistles. As always, we’ve rounded up a mix of developments, opportunities, and thoughtful reads from across the IP world along with a Bell of the Week that’s well worth revisiting. Bell of the Week: Who Really Drives Innovation? When we talk about innovation, we often think of businesses, entrepreneurs and the big breakthroughs they bring to the market. Governments, meanwhile, tend to be seen as playing a supporting role — funding research

SpicyIP Bells & Whistles: IP Events and Opportunities (13.10.2026) Read More »

Scroll to Top